UMR 1121, Laboratoire Agronomie et Environnement (LAE), Université de Lorraine- INRAe, Nancy, France.
Université de Lorraine, CNRS, L2CM, F-54000, Nancy, France.
Biomed Pharmacother. 2020 Nov;131:110762. doi: 10.1016/j.biopha.2020.110762. Epub 2020 Sep 29.
Phenolamides constitute a family of metabolites, widely represented in the plant kingdom, that can be found in all plant organs with a predominance in flowers and pollen grains. They represent a large and structurally diverse family, resulting from the association of phenolic acids with aliphatic or aromatic amines. Initially revealed as active compounds in several medicinal plant extracts, phenolamides have been extensively studied for their health-promoting and pharmacological properties. Indeed, phenolamides have been shown to exhibit antioxidant, anti-inflammatory, anti-cancer and antimicrobial properties, but also protective effects against metabolic syndrome and neurodegenerative diseases. The purpose of this review is to summarise this large body of literature, including in vitro and in vivo studies, by describing the diversity of their biological properties and our actual knowledge of the molecular mechanisms behind them. With regard to their considerable pharmacological interest, the question of industrial production is also tackled through chemical and biological syntheses in engineered microorganisms. The diversity of biological activities already described, together with the active discovery of the broad structural diversity of this metabolite family, make phenolamides a promising source of new active compounds on which future studies should be focused.
酚酰胺构成了一类代谢产物,广泛存在于植物界中,可以在所有植物器官中找到,在花和花粉粒中更为常见。它们代表了一个庞大且结构多样的家族,是由酚酸与脂肪族或芳香族胺结合而成的。最初在几种药用植物提取物中被发现是具有活性的化合物,酚酰胺因其具有促进健康和药理学特性而被广泛研究。事实上,酚酰胺已被证明具有抗氧化、抗炎、抗癌和抗菌特性,但也对代谢综合征和神经退行性疾病具有保护作用。本文综述的目的是总结大量的文献,包括体外和体内研究,通过描述其生物特性的多样性以及我们对其分子机制的现有认识。鉴于其具有相当大的药理学意义,还通过工程微生物中的化学和生物合成来解决工业生产的问题。已经描述的生物活性的多样性,以及对这种代谢产物家族广泛结构多样性的积极发现,使得酚酰胺成为新的有活性化合物的有前途的来源,未来的研究应该集中在这方面。